Efficacy and Safety of Evobrutinib in Relapsing Multiple Sclerosis: A Systematic Review of Randomized Controlled Trials. magna-neurologica 2025, 3 (2), 138-149. https://doi.org/10.20961/magnaneurologica.v3i2.1929.